4//SEC Filing
Pichardo Susana 4
Accession 0001104659-22-099001
CIK 0001787640other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 9:11 PM ET
Size
13.9 KB
Accession
0001104659-22-099001
Insider Transaction Report
Form 4
Pichardo Susana
SVP, ACCOUNTING
Transactions
- Sale
Common Stock, par value $0.01 per share
2022-09-07$10.50/sh−71,651$751,992→ 0 total - Exercise of In-Money
Common Stock, par value $0.01 per share
2022-09-07$6.76/sh+29,856$201,827→ 71,651 total - Exercise of In-Money
Stock Option (right to buy)
2022-09-07−41,795→ 0 totalExercise: $7.94Exp: 2030-03-02→ Common Stock, par value $0.01 per share (41,795 underlying) - Exercise of In-Money
Common Stock, par value $0.01 per share
2022-09-07$7.94/sh+41,795$331,852→ 41,795 total - Exercise of In-Money
Stock Option (right to buy)
2022-09-07−29,856→ 47,765 totalExercise: $6.76Exp: 2030-03-02→ Common Stock, par value $0.01 per share (29,856 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.49 to $10.515, inclusive. The reporting person undertakes to provide to Convey Health Solutions Holdings, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The options, together representing a right to purchase 119,416 shares, consist of (i) 59,708 time-vesting options and (ii) 59,708 performance-vesting options. Time-vesting options are subject to a five-year time-based vesting schedule, with 20% vesting on September 4, 2020 and the remainder vesting in 16 equal installments every three months thereafter. Performance-vesting options vest over a five-year performance period commencing in 2019, with 20% of the stock options eligible to vest each year of the performance period based on achievement of certain financial metrics.
- [F3]Exercise price reflects a reduction of $1.18 per award from original exercise price of $7.94 as part of a special dividend as previously disclosed in the Company's proxy statement for its 2022 annual meeting of stockholders.
Documents
Issuer
Convey Health Solutions Holdings, Inc.
CIK 0001787640
Entity typeother
Related Parties
1- filerCIK 0001867588
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 9:11 PM ET
- Size
- 13.9 KB